Tate & Lyle has announced the appointment of Vivid Sehgal as the company’s new chief financial officer (CFO), effective 1 May 2021.
Sehgal succeeds Imran Nawaz, who has served as CFO since 2018 when he took over the role from Nick Hampton, who had been appointed as Tate & Lyle CEO. Nawaz will be leaving the company to take up the position of Tesco CFO.
At the beginning of March, Sehgal will join Tate & Lyle as CFO designate and be appointed to the board of directors. Over the following two months, he will work with Nawaz to ensure a smooth transition.
Previously, Sehgal served as CFO of Delphi Technologies from 2017 to 2020 and prior to that, he was CFO of LivaNova, a medical technology company.
Sehgal has also held senior management positions with Allergan, Gillette and GlaxoSmithKline, working across the US, Europe and the Middle East.
“I am delighted to welcome Vivid to Tate & Lyle and the executive team,” said Tate & Lyle chief executive, Nick Hampton.
“He brings with him a proven track record of financial leadership as well as extensive commercial and transactional experience. I very much look forward to working with him as we continue to progress Tate & Lyle’s growth agenda.”
Tate & Lyle chairman, Gerry Murphy, added: “Vivid’s broad financial, business and international experience will be of great value to Tate & Lyle and he is a very welcome addition to our board.”
by Antonia Garrett Peel
Heineken announces that, following United Breweries Limited’s (UBL) annual general meeting on 29 July 2021, it has obtained control of UBL in India.
Collaboration has been a vital driver of Ferrero’s sustainability journey, and the company has developed long-standing partnerships with trusted suppliers.
NovoNutrients is making moves to scale its process that uses industrial carbon dioxide emissions, cheap hydrogen and naturally occurring microbes to create high-grade proteins for human and animal consumption.